Literature DB >> 17720035

Rehabilitation and recovery in schizophrenia.

Dawn I Velligan1, Jodi M Gonzalez.   

Abstract

The combination of new medications and effective psychosocial rehabilitation interventions has the potential to improve outcomes for individuals with schizophrenia significantly. Patients who have persistent positive symptoms can benefit from cognitive behavior therapy. Impairments in social competence can be addressed with social skills training. Supported employment programs may increase the ability of patients who have schizophrenia to obtain competitive employment. Family psychoeducational approaches, treatments for comorbid substance abuse, and cognitive rehabilitation approaches that enhance or bypass impairments in cognitive functioning are discussed. This article describes current efforts to incorporate these evidence-based principles of rehabilitative medicine into the management of schizophrenia.

Entities:  

Mesh:

Year:  2007        PMID: 17720035     DOI: 10.1016/j.psc.2007.05.001

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  9 in total

1.  The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia.

Authors:  Dawn I Velligan; Pamela M Diamond; Jim Mintz; Natalie Maples; Xueying Li; John Zeber; Larry Ereshefsky; Yui-Wing F Lam; Desiree Castillo; Alexander L Miller
Journal:  Schizophr Bull       Date:  2007-10-10       Impact factor: 9.306

2.  Patient and Provider Perspectives on Medication Non-adherence Among Patients with Depression and/or Diabetes in Diverse Community Settings - A Qualitative Analysis.

Authors:  Jane E Hamilton; Eduardo Blanco; Salih Selek; Kelly L Wirfel; Elmer V Bernstam; Dawn Velligan; Meghana Gudala; Kirk Roberts
Journal:  Patient Prefer Adherence       Date:  2022-06-30       Impact factor: 2.314

Review 3.  Affective traits in schizophrenia and schizotypy.

Authors:  William P Horan; Jack J Blanchard; Lee Anna Clark; Michael F Green
Journal:  Schizophr Bull       Date:  2008-07-29       Impact factor: 9.306

Review 4.  Cognitive remediation in schizophrenia.

Authors:  Alice Medalia; Jimmy Choi
Journal:  Neuropsychol Rev       Date:  2009-05-15       Impact factor: 7.444

5.  Multimodal cognitive therapy: combining treatments that bypass cognitive deficits and deal with reasoning and appraisal biases.

Authors:  Dawn I Velligan; Meredith Draper; Donna Stutes; Natalie Maples; Jim Mintz; Sara Tai; Douglas Turkington
Journal:  Schizophr Bull       Date:  2009-07-20       Impact factor: 9.306

Review 6.  Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy.

Authors:  Katherine E Burdick; Raphael J Braga; Joseph F Goldberg; Anil K Malhotra
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophrenia.

Authors:  Dawn Velligan; Jim Mintz; Natalie Maples; Li Xueying; Stephanie Gajewski; Heather Carr; Cynthia Sierra
Journal:  Schizophr Bull       Date:  2012-10-19       Impact factor: 9.306

8.  An Integrated Recovery-oriented Model (IRM) for mental health services: evolution and challenges.

Authors:  Barry G Frost; Srinivasan Tirupati; Suzanne Johnston; Megan Turrell; Terry J Lewin; Ketrina A Sly; Agatha M Conrad
Journal:  BMC Psychiatry       Date:  2017-01-17       Impact factor: 3.630

9.  Trait emotional experience in individuals with schizophrenia and youth at clinical high risk for psychosis.

Authors:  Claire I Yee; Gregory P Strauss; Daniel N Allen; Claudia M Haase; David Kimhy; Vijay A Mittal
Journal:  BJPsych Open       Date:  2019-09-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.